🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 1, first-in-human, randomized, double-blind, placebo-contro...
Status
Completed
Location
Scientia Clinical Research Ltd
Start Date
2021-09-27
Trial ID
NCT05112159
A Phase 1, Randomized, Double-blind, Placebo-controlled Study of Orally Adm...
Status
Completed
Location
Labcorp Cru
Start Date
2022-08-08
Trial ID
NCT05349097
Treatments Being Tested
This is a randomized, double-blind, and placebo-controlled phase I clinical...
Status
Completed
Location
The Second Hospital of Anhui Medical University
Start Date
2022-08-08
Trial ID
NCT05504746
Treatments Being Tested
A randomized, double-blind, placebo-controlled trial design was used to ass...
Status
Unknown
Location
The Affiliated Hospital of Qingdao University
Start Date
2022-06
Trial ID
NCT05409326
Treatments Being Tested
This is a phase 1, 2-part, double-blind (sponsor-unblinded), randomized, pl...
Status
Terminated
Location
GSK Investigational Site
Start Date
2019-06-17
Trial ID
NCT03984812
Treatments Being Tested
A Phase Ⅰ, Single and Multiple Ascending Dose escalation, and Food-Effect S...
Status
Completed
Location
Beijing Municipality - Beijing Municipality - No. 101, Luyuan East Road, Tongzhou District, Beijing
Start Date
2025-09-04
Trial ID
NCT07616791
Treatments Being Tested
To evaluate the safety and tolerance of single and multiple administrations...
Status
Active Not Recruiting
Location
Shenzhen People's Hospital
Start Date
2023-01-10
Trial ID
NCT07030504
Treatments Being Tested
This trial is a phase 1, randomized, double-blind, placebo-controlled trial...
Status
Completed
Location
The First Hospital of China Medical University
Start Date
2023-11-21
Trial ID
NCT07103369
Treatments Being Tested
The aim of this 4-weeks randomized double-blind placebo-controlled single a...
Status
Completed
Location
Clinical Research Unit
Start Date
2020-03-16
Trial ID
NCT06040372
This clinical trial is the first-in-human study of CU06-1004. The purpose o...
Status
Completed
Location
Celerion
Start Date
2021-07-15
Trial ID
NCT04795037
Treatments Being Tested